ResearcherHôpital BeaujonNo recent work listed
Roger Faroux
Matched on ORCID iD 0000-0003-4222-8989; OpenAlex author ID A5003768763. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2013: 1 trial · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper
Papers 4
- Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial. Co-author DOI 10.1001/jamaoncol.2022.3829↗
- Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized … Co-author DOI 10.1016/j.ejca.2019.10.020↗
- Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label,… Co-author DOI 10.1016/j.ejca.2020.02.004↗
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. Co-author DOI 10.1056/nejmoa1809775↗
Trials 1
- PAncreatic Adenocarcinoma in Hospital Principal investigator NCT01989624↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Pascal R. Hammel · 3 shared papers, 2018–2020 · strength 0.22
- Paper Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancr… DOI 10.1016/j.ejca.2019.10.020↗
- Paper Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of ad… DOI 10.1016/j.ejca.2020.02.004↗
- Paper FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. DOI 10.1056/nejmoa1809775↗
- Jean-Baptiste Bachet · 3 shared papers, 2018–2020 · strength 0.22
- Paper Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancr… DOI 10.1016/j.ejca.2019.10.020↗
- Paper Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of ad… DOI 10.1016/j.ejca.2020.02.004↗
- Paper FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. DOI 10.1056/nejmoa1809775↗
- Iman El Hariry · 2 shared papers, 2020 · strength 0.17
- Paper Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancr… DOI 10.1016/j.ejca.2019.10.020↗
- Paper Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of ad… DOI 10.1016/j.ejca.2020.02.004↗
- Christophe Louvet · 2 shared papers, 2020 · strength 0.17
- Paper Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancr… DOI 10.1016/j.ejca.2019.10.020↗
- Paper Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of ad… DOI 10.1016/j.ejca.2020.02.004↗
- Jerome F. Cros · 2 shared papers, 2020 · strength 0.17
- Paper Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancr… DOI 10.1016/j.ejca.2019.10.020↗
- Paper Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of ad… DOI 10.1016/j.ejca.2020.02.004↗
- Christophe Tournigand · 2 shared papers, 2020 · strength 0.17
- Paper Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancr… DOI 10.1016/j.ejca.2019.10.020↗
- Paper Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of ad… DOI 10.1016/j.ejca.2020.02.004↗
- Fabienne Portalès · 2 shared papers, 2020 · strength 0.17
- Paper Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancr… DOI 10.1016/j.ejca.2019.10.020↗
- Paper Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of ad… DOI 10.1016/j.ejca.2020.02.004↗
- Christelle de la Fouchardière · 2 shared papers, 2020 · strength 0.17
- Paper Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancr… DOI 10.1016/j.ejca.2019.10.020↗
- Paper Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of ad… DOI 10.1016/j.ejca.2020.02.004↗
- Thierry André · 2 shared papers, 2020 · strength 0.17
- Paper Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancr… DOI 10.1016/j.ejca.2019.10.020↗
- Paper Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of ad… DOI 10.1016/j.ejca.2020.02.004↗
- David Tougeron · 2 shared papers, 2020 · strength 0.17
- Paper Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancr… DOI 10.1016/j.ejca.2019.10.020↗
- Paper Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of ad… DOI 10.1016/j.ejca.2020.02.004↗
- Olivier Bouché · 2 shared papers, 2020 · strength 0.17
- Paper Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancr… DOI 10.1016/j.ejca.2019.10.020↗
- Paper Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of ad… DOI 10.1016/j.ejca.2020.02.004↗
- Patrick Rat · 1 shared paper, 2018 · strength 0.05
- Frédéric Di Fiore · 1 shared paper, 2018 · strength 0.05
- Marc Ychou · 1 shared paper, 2018 · strength 0.05
- Thierry Conroy · 1 shared paper, 2018 · strength 0.05
- James Biagi · 1 shared paper, 2018 · strength 0.05
- Mohamed Hebbar · 1 shared paper, 2018 · strength 0.05
- Petr Kavan · 1 shared paper, 2018 · strength 0.05
- Alain Sauvanet Sauvanet · 1 shared paper, 2018 · strength 0.05
- David Malka · 1 shared paper, 2018 · strength 0.05
- Eric Assénat · 1 shared paper, 2018 · strength 0.05
- Jean-Luc Raoul · 1 shared paper, 2018 · strength 0.05
- Alice Chia-Chi Wei · 1 shared paper, 2018 · strength 0.05
- Éric François · 1 shared paper, 2018 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.